PharmaTalkRadio
By Conference Forum
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Conference Forum
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 545
Description
PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.
| Episode | Date |
|---|---|
|
Unlocking Unstructured Data with AI for Optimized Protocol Development
|
Jun 02, 2026 |
|
Bridging Access Gaps: Sponsor-Led Enablement of Research-Naïve Sites to Expand Patient Reach
|
May 08, 2026 |
|
Building Trust-Driven Partnerships: AstraZeneca’s Concierge Approach to Accelerating Site Activation and Enrollment
|
May 08, 2026 |
|
Eli Lilly on Site Enablement: Co-Designing Solutions with Sites
|
May 08, 2026 |
|
What a Strategic Partnership Looks Like in Practice: Inside the Takeda–Basil Collaboration That Delivered Tenfold Enrollment
|
May 08, 2026 |
|
Using Digital Technologies to Enhance Patient Experience and Better Manage Supply Chain
|
May 05, 2026 |
|
Ensuring Sustainability Throughout Drug and Device Development
|
May 05, 2026 |
|
Utilizing AI to Facilitate Combination Product Development
|
May 05, 2026 |
|
Achieving Effective Manufacturing Scaleup for Clinical and Commercial Success
|
May 05, 2026 |
|
Advances and Opportunities in Dual Chamber Injectables
|
May 05, 2026 |
|
How Evinova is Integrating AI into Clinical Development to Bring Big Impact to Big Pharma
|
Feb 24, 2026 |
|
How Bayer Reorganized Their Clinical Operations Structure for Efficiency and Cost Savings
|
Jan 29, 2026 |
|
How Amicus Embedded Patient Advocacy into its Corporate DNA
|
Jan 29, 2026 |
|
Designing Clinical Trials Balancing Simplicity with Complexity
|
Jan 27, 2026 |
|
Platform Approaches to Streamline Combination Product Development
|
Jan 27, 2026 |
|
What is the State of Clinical Trial Patient Matching Right Now?
|
Dec 19, 2025 |
|
Balancing Innovation and Practicality in Immuno-Oncology Dose Selection
|
Dec 19, 2025 |
|
Leveraging Local HCPs to Decentralize Clinical Research in North Carolina
|
Dec 19, 2025 |
|
Using Patient Engagement and Digital Innovation to Elevate Patient Insights and Outcomes
|
Dec 19, 2025 |
|
What to Expect at the 2026 Patients as Partners in Clinical Research Conference
|
Dec 18, 2025 |
|
The Role of the CMO in BD and M&A Partnering with Pharma
|
Dec 12, 2025 |
|
Advances in Payload Delivery and Drug Conjugation
|
Dec 12, 2025 |
|
Building Up a CMO Team as Your Company Evolves
|
Dec 01, 2025 |
|
Beyond LNPs: Delivering Genetic Medicines with Novel Vehicles
|
Dec 01, 2025 |
|
Pfizer on Advancing Data Analysis Capabilities through A New EDC/CDMS Platform
|
Nov 24, 2025 |
|
Insights from Tufts CSDD into Evolving Trial Partnerships Models
|
Nov 24, 2025 |
|
ADCs, Chemotherapy, and Checkpoint Blockade in Urothelial Carcinoma
|
Nov 24, 2025 |
|
Understanding the Immunological Effects of Radiopharmaceuticals
|
Nov 24, 2025 |
|
How J&J Is Integrating Patient Centricity Across the Enterprise
|
Nov 19, 2025 |
|
Biogen's Nicole Murphy on Drug Delivery Innovation and the Acquisition of Alcyone Therapeutics
|
Nov 19, 2025 |
|
What to Expect at the 2026 IO360° Summit
|
Nov 12, 2025 |
|
CMOs Working Flexibly with Consultants and Fractional Expertise
|
Nov 03, 2025 |
|
Principles and Strategies for Designing Best-in-Class Immuno-Oncology ADCs
|
Oct 24, 2025 |
|
How Patient Organizations are Bridging Patient Inclusivity Gaps at the Site-Level
|
Oct 24, 2025 |
|
How Roche Reduced Unnecessary Protocol Amendments to Impact Timeline and Cost
|
Oct 21, 2025 |
|
How to Embed Clinical Research in Rural and Frontier Health Systems
|
Oct 21, 2025 |
|
Optimizing the Value Proposition in Small Companies with Limited Budgets
|
Sep 30, 2025 |
|
From the DPHARM 2024 Archives: Biogen Pilot on Using Vocal Biomarkers to Identify Potential Participants for Clinical Trials
|
Sep 26, 2025 |
|
Merck on Enhancing Trial Participation, Relevance, and Impact through Patient and Community Engagement
|
Sep 26, 2025 |
|
Ensuring Continuity in Patient Insights to Strengthen Medicine Development
|
Aug 22, 2025 |
|
Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach
|
Aug 22, 2025 |
|
Stanford's Dr Crystal Mackall on the Evolution of and Future Directions in Cell Therapy
|
Aug 14, 2025 |
|
De-Risking Clinical Operations by Taking a Scaffolding Approach to Outsourcing
|
Aug 12, 2025 |
|
Balancing Between Concentration and Volume when Developing Patient-Centric Biologics
|
Aug 12, 2025 |
|
Directors' Talk DPHARM 2025 - AI Sessions; Part III
|
Jul 25, 2025 |
|
Innovations in Manufacturing to Make CAR-T More Accessible and Affordable
|
Jul 25, 2025 |
|
Achieving Oral Delivery of Peptides through Formulation and Molecule Design Approaches
|
Jul 25, 2025 |
|
Catalyzing Change: The Business Imperative of Patient-Centric Drug Development
|
Jul 21, 2025 |
|
How Emerging Biopharma CMOs Can Better Partner with Patient Organizations
|
Jul 21, 2025 |
|
Joint Site and Sponsor Perspectives on Innovative Solutions Addressing Sites Challenges
|
Jul 21, 2025 |
|
What to Expect at the CRAACO: Clinical Research as a Care Option 2025 Event
|
Jul 08, 2025 |
|
Directors' Talk PODD 2025 - Keynotes & Key Themes
|
Jun 30, 2025 |
|
Enhanced Strategic FDA Collaboration: Working with CDER and CBER
|
Jun 26, 2025 |
|
Biomaterial Implants to Reduce Patient Burden and Improve Adherence
|
Jun 26, 2025 |
|
Are Site Networks the Solution to the Industry Productivity and Recruitment Challenge?
|
Jun 25, 2025 |
|
2025 Biotech Markets & Immuno-Oncology Outlook
|
Jun 25, 2025 |
|
Directors' Talk DPHARM 2025 - Pharma from the Trenches; Part II
|
Jun 17, 2025 |
|
Directors' Talk DPHARM 2025 - Keynotes & Key Topics; Part I
|
Jun 11, 2025 |
|
Streamlining Effective Patient Engagement through Pharma-Patient Advocacy Collaboration
|
Jun 05, 2025 |
|
Lessons Learned in the Development and Introduction of Closed Loop Systems
|
May 21, 2025 |
|
Best Practices and Potential Pitfalls Enriching Clinical Trials with PROs
|
May 21, 2025 |
|
Operationalizing the Patient Voice for Long-Term Protocol Planning and Execution
|
May 19, 2025 |
|
Navigating Data Quality and Scalability Challenges when Using Real-World Data from EHRs
|
May 14, 2025 |
|
Addressing the Realities of Scaling T-Cell Therapies for Patient Access and Affordability
|
May 14, 2025 |
|
The Current Status of Patient Centricity in Medicine Development
|
May 14, 2025 |
|
Patients as Partners Caregiver Keynote - The Life-Changing Power of a Clinical Trial
|
Apr 28, 2025 |
|
Bispecific Antibodies for PD-1 and VEGF: Impact and Market Dynamics for IO Landscape
|
Apr 23, 2025 |
|
Sustained Release Innovations to Reduce Patient Burden
|
Apr 22, 2025 |
|
How Pharma Is Adopting Generative AI Across Clinical Development
|
Apr 16, 2025 |
|
Tufts Center for Study of Drug Development on Evolving Clinical Trial Partnerships
|
Mar 31, 2025 |
|
New Approaches to Achieve Targeted Brain Delivery Without Increasing Toxicity
|
Mar 12, 2025 |
|
Partnering with Patients in Clinical Development Using the Biopsychosocial Model
|
Mar 05, 2025 |
|
Vaccine Delivery Innovations
|
Feb 26, 2025 |
|
How PALADIN Consortium Aims to Enhance Efficient Patient Advocacy-Industry Collaborations
|
Feb 25, 2025 |
|
What CMOs Need to Know and Do When Preparing for Product Launch
|
Feb 25, 2025 |
|
What to Expect at the 2025 Patients as Partners EU Conference
|
Feb 12, 2025 |
|
Understanding Financial Barriers to Getting More Coverage for Patients in Clinical Trials
|
Feb 12, 2025 |
|
How Montefiore Gets Early Stage Clinical Trials to Under-Resourced Communities
|
Jan 29, 2025 |
|
Investment Trends in Immuno-Oncology
|
Jan 22, 2025 |
|
Advances in Pulmonary Delivery of Biologics
|
Jan 22, 2025 |
|
Strategies for CMOs to Scale Up Effectively as Their Biotech Company Evolves
|
Jan 14, 2025 |
|
Boehringer Ingelheim on Collaborations in Clinical Development for Launch Readiness
|
Jan 14, 2025 |
|
Payer Perspectives on Drug Delivery
|
Dec 16, 2024 |
|
Patient Engagement: Practical Approaches for Emerging Biotech CMOs
|
Dec 16, 2024 |
|
Immuno-Oncology Debate 2024 on Solving Cancer’s Top Challenges
|
Dec 09, 2024 |
|
CMO Misunderstandings about Clinical Operations and How to Improve
|
Dec 05, 2024 |
|
How Roche is Maximizing the Impact of Patient Insights in Early Development
|
Dec 03, 2024 |
|
Designing and Developing Drug Delivery for Lower and Middle-Income Countries
|
Nov 21, 2024 |
|
Making Clinical Research a Feasible Care Option Using Modern Software Infrastructure
|
Nov 19, 2024 |
|
Innovative Approach for Elevating Patient-Centric Solutions in Pediatric Trials
|
Nov 08, 2024 |
|
Using Patient Insights Meaningfully throughout the Medicine & Disease Lifecycle
|
Nov 08, 2024 |
|
Incorporating Quantitative Values of Patient Perspectives into Trial Design
|
Oct 25, 2024 |
|
Accessing a Novel Source of Patient Experience Data to Improve Clinical Research
|
Oct 24, 2024 |
|
Empathy and Behavioral Science in ePROs to Increase Data Collection Adherence
|
Oct 23, 2024 |
|
Antiviral Drug Development: Overcoming Challenges to the Current Model
|
Oct 11, 2024 |
|
Strategies to Empower Clinical Sites, Streamline Trials and Enhance Patient Care
|
Oct 09, 2024 |
|
Unlocking Pre-Enrollment Data to Help Sponsors Recruit and Enroll More Patients
|
Oct 09, 2024 |
|
The History of Tumor Vaccines, and Why the Newest RNA Cancer Vaccines Might Work
|
Oct 07, 2024 |
|
What Biotech CEOs Need to Know about Developing a Commercialization Roadmap
|
Oct 04, 2024 |
|
Simplicity in Technology Delivery for Clinical Trials
|
Sep 20, 2024 |
|
Micromachines, Biologic Approaches and New Tools Pushing the Boundaries in Oral
|
Sep 19, 2024 |
|
Combining AI and Empirical Science to Advance Cancer Immunotherapies
|
Sep 13, 2024 |
|
The Personal Impact of a Clinical Trial
|
Sep 12, 2024 |
|
The Future of Patient-Centricity: Advancing Frameworks to Achieve Greater Impact
|
Aug 08, 2024 |
|
Using AI to Accelerate the Next Generation of Oncology Immunotherapies
|
Aug 07, 2024 |
|
Immuno-Oncology Cell Therapy Data Analytics: What and How to Measure
|
Jul 29, 2024 |
|
What to Expect at CRAACO: Clinical Research as a Care Option 2024, in 5 Minutes
|
Jul 25, 2024 |
|
How to Enhance Clinical Trial Participation in Diverse Linguistic Backgrounds
|
Jul 23, 2024 |
|
Patient Engagement Advocate on Collaborating Successfully with Pharma
|
Jul 16, 2024 |
|
What to Expect at DPHARM 2024, with DPHARM Directors
|
Jul 09, 2024 |
|
Astellas Head of Patient Centricity on Patient-Centric Medicine Development
|
Jul 08, 2024 |
|
Preferences in Decentralization and Digitalization of Pediatric Clinical Trials
|
Jun 24, 2024 |
|
How CMOs Build a Network of Consultants
|
Jun 07, 2024 |
|
What CMOs Need to Know about Partnering with Hospitals & Clinical Research Sites
|
Jun 07, 2024 |
|
Transitioning from Early Stage to Registrational/Pivotal Stage Development
|
Jun 06, 2024 |
|
CMO Insights and Advice on Tailoring Your Pitch to Investors
|
Jun 06, 2024 |
|
Discoveries from the Clinic that Help Inform IO Cell Therapy Moving Forward
|
Jun 05, 2024 |
|
Using Sustainability to Empower Patient Engagement Goals in Medicine Development
|
Jun 05, 2024 |
|
The CMO as a Translational Scientist
|
Jun 04, 2024 |
|
Maximizing Regulatory Interactions
|
Jun 04, 2024 |
|
Delivering Exceptional Clinical Trial Experiences for Patients
|
May 02, 2024 |
|
Optimizing the Integration of Mobile and Patient-Facing Tech in Clinical Trials
|
May 02, 2024 |
|
ctDNA Potential for Prognostic Stratification, Tumor Insights & Drug Development
|
May 01, 2024 |
|
What to Expect at the 2024 Patients as Partners EU Conference
|
Apr 23, 2024 |
|
Taking Lessons from Manufacturing Immunotherapies to Accelerate Development
|
Apr 12, 2024 |
|
Enhancing Solubility with Novel Excipient Technologies
|
Apr 08, 2024 |
|
Measuring the Value of DCTs and Hybrid Models
|
Apr 02, 2024 |
|
Navigating and Adopting Innovation in a Post- Pandemic World
|
Mar 29, 2024 |
|
Turning a Search for Lung Cancer Biomarkers into a Patient Empowerment Community
|
Mar 15, 2024 |
|
Engaging All Stakeholders for Clinical Trial Patient Engagement and Value
|
Mar 12, 2024 |
|
Optimizing Medicine Development for Real-World Efficacy in Patients
|
Feb 26, 2024 |
|
Prioritizing Development Programs that Align with Fundraising Catalysts
|
Jan 30, 2024 |
|
How CMOs can Support the Overarching Process of a Fundraising
|
Jan 30, 2024 |
|
Developing Internal and External Communication Strategies
|
Jan 29, 2024 |
|
Interacting with Different Types of Investors as a CMO
|
Jan 29, 2024 |
|
What CMOs Need to Know About Medical Affairs
|
Jan 28, 2024 |
|
The Promise and Challenges of Ultrasound-Mediated Delivery
|
Jan 09, 2024 |
|
Achieving Targeted Delivery of Gene Editing Therapies
|
Jan 09, 2024 |
|
New Approaches in CNS/PNS Delivery
|
Jan 08, 2024 |
|
The Future of Digital Technology in the Connected Device Space
|
Jan 08, 2024 |
|
Delivery Challenges from the Oncology Pipeline
|
Jan 07, 2024 |
|
Precision Ophthalmic Delivery
|
Jan 07, 2024 |
|
Overcoming Barriers to Adoption of Transdermal Delivery
|
Jan 04, 2024 |
|
Novel Nasal Products and Formulations
|
Jan 04, 2024 |
|
Evolving US Clinical Trial Infrastructure for Better Trials & Emergency Response
|
Dec 20, 2023 |
|
Addressing the Clinical Operations Workforce Gap
|
Dec 20, 2023 |
|
Patients on How R&D Organizations Can Better Operationalize Trials for Patients
|
Dec 14, 2023 |
|
Community Organization Perspectives on Improving Clinical Trial Initiatives
|
Dec 14, 2023 |
|
How Henry Ford Health Integrated Clinical Trials into Clinical Care
|
Oct 26, 2023 |
|
Novartis’ Approach to Making Patients Feel Valued in Clinical Research
|
Oct 26, 2023 |
|
Democratizing Access: Enabling All Care Locations to be Research Locations
|
Oct 25, 2023 |
|
Reimbursement Challenges with Clinical Trials
|
Oct 25, 2023 |
|
Strategies for Building a Successful Clinical Research Team in the Care Setting
|
Oct 24, 2023 |
|
How to Optimize Inventory and Sample Management for Clinical Trial Health
|
Oct 04, 2023 |
|
Ensuring That Sites Are Set Up for Trial Success, Using Data and Technology
|
Aug 29, 2023 |
|
Innovating Patient Recruitment: A Conversation with BBK Worldwide Founders
|
Aug 07, 2023 |
|
10th Annual Mobile Tech in Clinical Trials: What to Expect in under 10 Minutes
|
Jul 28, 2023 |
|
CRAACO Director's Note Podcast on What to Expect in Under 6 Minutes
|
May 10, 2023 |
|
Current Challenges in Vaccine Delivery and Distribution
|
Jan 23, 2023 |
|
Providing the Right Level of Value to the Patient that Creates Value
|
Jan 20, 2023 |
|
Enhancing the Interferon Pathway to Attack Cancer
|
Jan 19, 2023 |
|
Innovative CRISPR-based Editing to Create Off-the-shelf Immune Cell Therapies
|
Jan 18, 2023 |
|
Investment Trends in IO
|
Jan 17, 2023 |
|
Investment and Collaboration Strategies in Cell and Gene Therapy
|
Jan 16, 2023 |
|
Mechanisms of Immune Evasion Mediated by Hypoxia- Inducible Factors
|
Jan 14, 2023 |
|
Neoadjuvant Immune Checkpoint Blockade: A Window into Treatment Response and Pri
|
Jan 13, 2023 |
|
Regeneron’s Approach to Strategic Collaborations, Licensing and Business Dev.
|
Jan 12, 2023 |
|
Panel: Targeted Radiotherapy and the Impact on IO
|
Jan 11, 2023 |
|
What’s Next on the IO Radar? Top 10 Recommendations from Dr Andrew Baum, Citi
|
Jan 10, 2023 |
|
KEYNOTE FIRESIDE CHAT with Dr Robert Langer and Dr Ester Caffarel-Salvador
|
Jan 10, 2023 |
|
Panel: Role of China in the BD Process
|
Jan 09, 2023 |
|
Gaining “Hard-to-Reach” Patients’ Input During the Global COVID Pandemic
|
Jan 06, 2023 |
|
How Janssen is Collaboratively Working with Patients and Sites to Advance DCTs
|
Jan 05, 2023 |
|
How Merck is Partnering with Communities to Support Clinical Research
|
Jan 04, 2023 |
|
Sanofi’s New Initiatives Firmly Embedding Patient Experience & Perspectives
|
Jan 03, 2023 |
|
Reflections on Alnylam and Conquering Delivery
|
Jan 03, 2023 |
|
Patient Involvement Legal Barriers to Be Aware of and Pathways to Overcome Them
|
Jan 02, 2023 |
|
Next Generation Immune Checkpoints: Deciphering Key Roles in the TME
|
Jan 02, 2023 |
|
Merck Reporting on Site Monitoring, Performance and Database Lock
|
Dec 31, 2022 |
|
The Role of RWD in the Development of Remdesivir
|
Dec 30, 2022 |
|
De-risking Combination Product Development Involving L Volume Sub Formulations
|
Dec 30, 2022 |
|
How Regeneron Got an FDA Approved Therapy for COVID in Record Time
|
Dec 29, 2022 |
|
Remote Monitoring to Improve Transitioning Home and Reducing Risk of Readmission
|
Dec 28, 2022 |
|
The Pfizer Pledge: Getting to 60% Remote Clinical Trials in 2022
|
Dec 27, 2022 |
|
Benchmarking Clinical Operations for Digital Maturity
|
Dec 26, 2022 |
|
Innovative Trial Designs to Reduce Patient, Site and Investigator Burden
|
Dec 23, 2022 |
|
Addressing the Lack of Structured, Clean Patient Data
|
Dec 22, 2022 |
|
Fireside Leadership Lessons: Driving Innovation to Support Patients and Sites
|
Dec 21, 2022 |
|
Why Rare Disease Therapeutics Need Early Market Access Planning
|
Dec 21, 2022 |
|
Effective Concentration for a Longer Period with Long Acting Injectables
|
Dec 20, 2022 |
|
Moderna on Innovating Clinical Trial Partnerships to Expand Access
|
Dec 20, 2022 |
|
Regeneron and Novartis on Innovating to Accommodate Growing Pipelines
|
Dec 19, 2022 |
|
Development of the Lipid Nanoparticles
|
Dec 19, 2022 |
|
Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities
|
Dec 14, 2022 |
|
Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies
|
Dec 12, 2022 |
|
Chair’s Opening Presentation with Barbara Lueckel Summary
|
Dec 12, 2022 |
|
A Decade After Checkpoints- What Do We Know, What Do We Need to Know and Getting
|
Dec 08, 2022 |
|
Achieving Diversity and Inclusion in Oncology Clinical Trials
|
Dec 07, 2022 |
|
How Long-Acting Implantables Are Taking Extended Drug Release to the Next Level
|
Dec 07, 2022 |
|
Advancements in CART for the Treatment of Glioblastoma
|
Dec 06, 2022 |
|
From Carer to Trailblazer: One Man’s Fight to Impact Clinical Research
|
Dec 06, 2022 |
|
Cell & Gene Therapy: Current Landscape, Lessons Learned and Paths Forward
|
Dec 05, 2022 |
|
What to Expect at the IO360° Summit in 6 Minutes
|
Dec 05, 2022 |
|
Solving for the Digital Divide: Building Trust with Mobile Tech for Patients
|
Dec 02, 2022 |
|
How Moderna Built a Digital Organization to Transform How Clinical Research Gets
|
Dec 01, 2022 |
|
Roche’s Industry Overview on the Drug Delivery Landscape 2022
|
Nov 30, 2022 |
|
Leveraging Mobile Technologies in the Development of Novel Digital Endpoints
|
Nov 30, 2022 |
|
How Mobile Tech is Enabling Smarter Trial Designs for Better Data and Access
|
Nov 29, 2022 |
|
FDA Update on Digital Health Technologies in Clinical Trials Draft Guidance
|
Nov 28, 2022 |
|
Taking Patient Involvement in Clinical Publications to New Heights
|
Nov 28, 2022 |
|
Partnering with Your Compliance Teams to Advance Meaningful Collaboration
|
Nov 21, 2022 |
|
What Statisticians Wish They Could Tell Their Chief Medical Officers
|
Nov 17, 2022 |
|
Tackling the Manufacturing Complexity of Complex to Deliver Pipelines
|
Nov 16, 2022 |
|
Misaligned Incentives: Physician Perspectives on the Integration of CRAACO
|
Nov 16, 2022 |
|
Rewriting the Way We Work Together to Integrate Clinical Care and Research
|
Nov 15, 2022 |
|
Volunteering for a Vaccine Trial, Tackling Racial Disparities in Healthcare
|
Nov 14, 2022 |
|
How Amgen is RISING Above with Clinical Trial Diversity
|
Nov 14, 2022 |
|
A Vision for the Integration of Clinical Research and Care
|
Nov 11, 2022 |
|
Addressing Barriers to Patient Community Access through Non-Profit Partnerships
|
Nov 10, 2022 |
|
Educating Patients and Non-Research Physicians on Navigating Clinical Research
|
Nov 09, 2022 |
|
Long Acting Injectables for Biologics
|
Nov 09, 2022 |
|
Where and How DCTs Can Truly Enable and Close the Gaps between Research and Care
|
Nov 08, 2022 |
|
Partnering with Health Systems to Enhance Diverse Patient Access in Trials
|
Nov 07, 2022 |
|
Novartis’ Approach to Patient Engagement
|
Nov 07, 2022 |
|
Workforce Planning & Reducing Churn to Support and Promote CRAACO
|
Nov 04, 2022 |
|
Guest Keynote Connecting Communities with the CEO of Etsy
|
Nov 03, 2022 |
|
Making Institutional Change to Offer Clinical Research Options in Health Systems
|
Nov 02, 2022 |
|
Microgravity to Develop Crystalline Monoclonal Antibodies for Subcutaneous
|
Nov 02, 2022 |
|
CMO-CEO Fireside Discussion on Working Through Challenges
|
Nov 01, 2022 |
|
Building Trust to Ensure Diversity, Equity, Inclusion in Clinical Research
|
Oct 31, 2022 |
|
Drug Delivery Pipeline and Technologies, a Year in Review
|
Oct 26, 2022 |
|
How Eli Lilly is Diversifying and Engaging Patients Using DCT Capabilities
|
Oct 24, 2022 |
|
Advice for Partnering Between Innovator Drug Delivery Companies and Big Pharma
|
Oct 19, 2022 |
|
Fighting to be a True Stakeholder in Clinical Care and the Impact on Diversity
|
Oct 17, 2022 |
|
R&D Veteran on Leading a Biotech through Founding, IPO and Acquisition
|
Oct 14, 2022 |
|
The First 90 Days as a CMO
|
Oct 14, 2022 |
|
Building up a Company Through to Commercialization and Beyond
|
Oct 13, 2022 |
|
Best Practices for Cross Functional Communication Strategies for the CMO
|
Oct 12, 2022 |
|
Nicholas Warne Drug Delivery Industry
|
Oct 12, 2022 |
|
Managing the Partnership Between Big and Small Pharma
|
Oct 10, 2022 |
|
Infusing Patient Perspectives Across All of Pfizer
|
Oct 10, 2022 |
|
The Changing Environment Around Accelerated Approvals and Regulatory Pathways
|
Oct 07, 2022 |
|
Biotech Financing Options and Their Implications
|
Oct 06, 2022 |
|
Positioning Yourself For Board Roles and What to Expect as a CMO in Biotech
|
Oct 06, 2022 |
|
Building a Work Culture that Attracts and Retains Talent in Biotech
|
Oct 05, 2022 |
|
Exploring Ways to Reduce Costs of Developing & Manufacturing Drug Delivery Tech
|
Oct 05, 2022 |
|
Taking on the CMO Role at Moderna and Looking to the Future of Biotech R&D
|
Oct 04, 2022 |
|
What CMOs Must Know About How Patient Engagement Supports the Entire Biotech
|
Oct 03, 2022 |
|
Operationalizing the Integration of Patient Insights
|
Oct 03, 2022 |
|
How Sites Using Their Own Technology for Research Benefits All Stakeholders
|
Sep 29, 2022 |
|
Adjusting Your eCOA Strategy For Patient Centricity: Expert Advice
|
Sep 26, 2022 |
|
A Natural Language Collaboration That Helps Cancer Patients Navigate Treatment
|
Aug 31, 2022 |
|
Sandoz's Chief Operating Officer Discusses the New Initiative Act4Biosimilars
|
Aug 31, 2022 |
|
12th Annual DPHARM in Under 10 Minutes
|
Aug 06, 2022 |
|
Director's Notes on What to Expect at CRAACO: Clinical Research as a Care Option
|
Aug 04, 2022 |
|
What to Expect at Mobile Tech in Clinical Trials 2022
|
Aug 02, 2022 |
|
5 Minute Overview Podcast on What to Expect at PODD: Drug Delivery
|
Jul 19, 2022 |
|
Key Role of Strategy and Media in Improving Clinical Trial Enrollment Diversity
|
May 19, 2022 |
|
How CMOs Can Evaluate Potential Outsourcing Partners Effectively
|
May 02, 2022 |
|
Is the End of SDTM in Sight?
|
May 02, 2022 |
|
What Adapting During COVID-19 Taught Us About Innovating Drug Development
|
Apr 27, 2022 |
|
A Vision for the Future of Drug Delivery: Patients Interacting Less with Disease
|
Apr 15, 2022 |
|
On-the-Ground Perspective on Putting Decentralized Strategies in Clinical Trials
|
Apr 14, 2022 |
|
How Listening Tech Disrupts Clinical Research to Create Patient-Centric Trials
|
Apr 14, 2022 |
|
R&D Veteran Keynote, Dr Jo Viney, from Chief Medical Officer Summit 360° 2021
|
Feb 17, 2022 |
|
Biotech CEO Keynote, Dr Ron Cohen, from Chief Medical Officer Summit 360° 2021
|
Feb 17, 2022 |
|
10th Annual Chief Medical Officer Summit 360º in a Nutshell
|
Feb 15, 2022 |
|
The Case for Sites Using Their Own Tech to Accelerate Research and Reduce Burden
|
Jan 20, 2022 |
|
5 Talks to Watch (and Why) at IO360º 2022 with Strategic Advisor Dr Dan Chen
|
Jan 18, 2022 |
|
8th Annual Immuno-Oncology 360° Summit: What to Expect in 7 Minutes
|
Jan 02, 2022 |
|
Patients as Partners EU 2022 in 5 Minutes
|
Dec 17, 2021 |
|
How Artificial Intelligence Is Creating Better Clinical Trials, with Saama
|
Dec 03, 2021 |
|
Making the Leap from IV to Subcutaneous, with Halozyme's ENHANZE® Technology
|
Nov 23, 2021 |
|
J&J Vision on Progress in Eyecare and Meeting the Needs of Future Patients
|
Oct 21, 2021 |
|
Flexible Data Collection and Best DCT Strategies: Advice from an Expert
|
Oct 18, 2021 |
|
Building a Successful Relationship with your Development Partner
|
Oct 05, 2021 |
|
9th Annual Chief Medical Officer Summit 360° Overview in 5 Minutes
|
Aug 27, 2021 |
|
10 Year Review on Drug Delivery
|
Aug 17, 2021 |
|
8th annual Mobile in Clinical Trials in 5 Minutes
|
Aug 04, 2021 |
|
PODD 2021 in 7 Minutes with Director, Valerie Bowling
|
Jul 27, 2021 |
|
Ferring on Creating a First-in-Class Microbiome-Based Therapeutic
|
Jul 19, 2021 |
|
DPHARM in 10 Minutes with Director Valerie Bowling
|
Jul 12, 2021 |
|
The Biotech Incubator Helping Entrepreneurs Launch Companies to Advance Health
|
Jul 07, 2021 |
|
How and When to Pursue Decentralized Clinical Trials: Conversation with Experts
|
Jun 15, 2021 |
|
How to Utilize Technology to Truly Increase Diversity in Clinical Trials
|
Apr 15, 2021 |
|
Insights from CRAACO 2020 and Looking to the Future
|
Apr 09, 2021 |
|
The Practical Implementation of Sensors in the Changing Drug Development World
|
Jan 22, 2021 |
|
Patients as Partners Europe 2021 Overview in 5 Minutes
|
Jan 11, 2021 |
|
Innovations & Novel Approaches in IO Imaging & Assessing Responses
|
Dec 27, 2020 |
|
HLA Loss and the Impact on Immunotherapy
|
Dec 27, 2020 |
|
Cell & Gene Therapy Debate: Intrinsic Editing vs Systemic Combination
|
Dec 27, 2020 |
|
Operational Dynamics of Implementing & Managing Basket Trials
|
Dec 27, 2020 |
|
Overcoming Site Regulatory Issues to Optimize Clinical Quality
|
Dec 11, 2020 |
|
Evolution of Regulatory Policy For Cell/Gene Therapy
|
Nov 03, 2020 |
|
Centralized vs Decentralized Manufacturing
|
Nov 03, 2020 |
|
Next Generation Bispecifics in Solid Tumors
|
Nov 02, 2020 |
|
Ariella Chivil's Immunotherapy Trial Pathway
|
Nov 02, 2020 |
|
Insitu Vaccinations vs Systemic Neo-Epitope Vaccinations
|
Oct 30, 2020 |
|
What Do Next Generation of Immunotherapies Need to Look Like to Move the Needle?
|
Oct 30, 2020 |
|
Using Sensor Technology to Deploy Decentralized Trials and Improve Patient Care
|
Oct 29, 2020 |
|
Current Issues and Potential Solutions for Site Audit Readiness and Monitoring
|
Oct 26, 2020 |
|
5 Minute Overview of 8th Annual CMO Summit 360º
|
Oct 19, 2020 |
|
The Future of Clinical Research and the Innovation from the COVID-19 Pandemic
|
Oct 07, 2020 |
|
Connecting Care and Research for the Patient with a Decentralized Trial Model
|
Sep 30, 2020 |
|
Remote Monitoring for Clinical Research in the Digital Age
|
Sep 18, 2020 |
|
Solving for the Patient Retention Problem in Clinical Research
|
Sep 09, 2020 |
|
IO Combinations 360° Overview in 7 Minutes
|
Sep 08, 2020 |
|
Enabling Clinical Trial Continuity with Live Video Visits
|
Sep 08, 2020 |
|
Roche's Dr Barbara Lueckel's Opening Remarks and the 2018 Year in Review
|
Aug 26, 2020 |
|
How a Gene Therapy for Duchenne Muscular Dystrophy Came to Be
|
Aug 25, 2020 |
|
How a Covid-19 Research Study was Formed with Oracle, Javara and Wake Forest
|
Jul 27, 2020 |
|
IO Biomarker Discovery & Personalized Cancer Therapy Development with Personalis
|
Jun 19, 2020 |
|
The Impact of COVID-19 on Clinical Trials: Where are We? And Where are We Going?
|
Jun 18, 2020 |
|
7th Annual Mobile in Clinical Trials Overview in Under 5 Minutes
|
Jun 18, 2020 |
|
KPIs that Support Innovation for Patient-Engagement
|
May 10, 2020 |
|
Starbucks: Innovation for the End User Experience
|
May 09, 2020 |
|
Transparency and the Future of Patient Expectations
|
May 09, 2020 |
|
Turning Genes into Medicines: Gene Therapy for Genetic Disease
|
May 08, 2020 |
|
Formulation & Device Lifecycle Management for Biotherapeutics
|
May 08, 2020 |
|
Future Outlook for Novel Drug Delivery
|
May 07, 2020 |
|
Modality Fluid Development: Evolving Pipelines and Drug Delivery Solutions
|
May 07, 2020 |
|
MedTech Fireside Chat: The Journey of an Emerging Medical Device Company
|
May 06, 2020 |
|
Case Study: Forming and Managing a Drug Delivery Alliance
|
May 06, 2020 |
|
Supporting Business Models for Scaled Connected Health Drug Delivery Products
|
May 05, 2020 |
|
Utilizing Digital Health Data to Improve Management, Prevention & Wellness
|
May 05, 2020 |
|
Understanding Jansen's Metaphyseal Chondrodysplasia
|
May 05, 2020 |
|
The Collective Struggle to Evolve Data and Analytics Culture & Capabilities
|
May 04, 2020 |
|
Re-Thinking Clinical Development - Using Historical Data to Transform Trials
|
May 04, 2020 |
|
The Evolution of Using Real World Data to Create Trial Readiness Cohorts
|
May 03, 2020 |
|
The PD-FIDI: Developing a Digital Endpoint for Parkinson's Disease
|
May 03, 2020 |
|
Planning For and Addressing Missing Data in Mobile Clinical Trials
|
May 02, 2020 |
|
Balancing Innovation with Solid Common Sense to Deliver Innovative Medicines
|
May 02, 2020 |
|
Virtual Trials: What are We Striving for and Measurements of Success
|
May 01, 2020 |
|
Escaping Pilotville: How to Scale Mobile / Digital Deployment in Clinical Trials
|
May 01, 2020 |
|
Merck's Strategy to Mobilize Mobile Efforts and Engineer for Scale
|
Apr 30, 2020 |
|
What Does a Successful Digital Trial Look Like?
|
Apr 30, 2020 |
|
Advocating for People Managing Hermansky-Pudlak Syndrome
|
Apr 29, 2020 |
|
Maintaining Clinical Trial Patient Engagement in COVID with Be the Partner
|
Apr 29, 2020 |
|
Setting Up Therapeutic + Vaccine Programs for COVID-19: Lessons Learned
|
Apr 28, 2020 |
|
Understanding Spinal Muscular Atrophy: A Chief Scientific Officer's Perspective
|
Apr 14, 2020 |
|
Changing How We Treat Systemic Sclerosis
|
Mar 19, 2020 |
|
New Opportunities for Cell Therapy Combinations
|
Mar 10, 2020 |
|
PD1 Resistance with a Multi-Omic Approach
|
Mar 10, 2020 |
|
Updates on PARP Inhibition
|
Mar 09, 2020 |
|
Leveraging the Tumor Microenvironment for IO Therapy
|
Mar 08, 2020 |
|
Updates on Bintrafusp alfa/M7824 Clinical Data
|
Mar 07, 2020 |
|
NKTR-214: Harnessing the IL-2 Pathway in Combination Immunotherapies
|
Mar 06, 2020 |
|
Advancing Bispecifics for Combination Immunotherapy
|
Mar 02, 2020 |
|
How AI, Machine Learning and Big Data are Used to Inform Combinations
|
Mar 01, 2020 |
|
Weighing Your Options in Considering Clinical Trials from a Patient Perspective
|
Feb 20, 2020 |
|
Understanding the Goals of Care vs Research
|
Feb 19, 2020 |
|
6 Min Podcast on What to Expect at the 7th Annual Patients as Partners
|
Feb 18, 2020 |
|
How to Integrate Industry Sponsored Clinical Trials Into Your Health System
|
Feb 18, 2020 |
|
How Sanford Health Systems Increased Clinical Trial Participation to 10%
|
Feb 17, 2020 |
|
Keynote: Surgeon’s Perspective on Integrating Clinical Care & Clinical Research
|
Feb 14, 2020 |
|
How Wilmington Health is Streamlining Integration of Clinical Research & Care
|
Feb 13, 2020 |
|
Addressing Barriers Health Systems Face in Integrating Clinical Care & Research
|
Feb 12, 2020 |
|
Effectively Democratizing Access to Clinical Trials for All
|
Feb 11, 2020 |
|
Delivering an Innovative, Patient-Centric Delivery System
|
Feb 06, 2020 |
|
Ophthalmology: Exploring Other Routes of Administration
|
Feb 06, 2020 |
|
Transforming Cardiovascular Treatment with Pulmonary Delivery
|
Feb 05, 2020 |
|
MRI-Guided Focused Ultrasound and the Delivery of Therapeutics to the Brain
|
Feb 05, 2020 |
|
Better Strategies to Inform Patients on Clinical Research & Trial Participation
|
Jan 23, 2020 |
|
Chief Patient Advocate/Officer: Driving Culture Change from the Top Down
|
Jan 23, 2020 |
|
How Novartis Includes Patient Input into All Aspects of a Clinical Study
|
Jan 22, 2020 |
|
Patients as Partners in Clinical Research EU 5 Min Upcoming Conf Summary
|
Jan 06, 2020 |
|
Partnering with Patients on Clinical Development Protocols
|
Dec 20, 2019 |
|
Improving Clinical Research and Trials Through Pharma/Advocacy Partnerships
|
Dec 19, 2019 |
|
Engaging with Communities to Educate and Enroll Diverse Populations
|
Dec 19, 2019 |
|
Mapping Out the Patient Decision Journey
|
Dec 18, 2019 |
|
FDA Patient Engagement Synergistic Efforts
|
Dec 17, 2019 |
|
The Democratization of Patient Data Ownership: Returning Results
|
Dec 16, 2019 |
|
Cell & Gene Therapy Day Overview in 4 minutes
|
Dec 04, 2019 |
|
2020 Immuno-Oncology 360° Summit Overview in 10 Minutes
|
Dec 04, 2019 |
|
Fireside Chat with an R&D Veteran
|
Dec 03, 2019 |
|
Designing Clinical Trials for Gene Therapy - A Paradigm Shift
|
Dec 03, 2019 |
|
Case Study: Life of a Chief Medical Officer Pre and Post IPO
|
Dec 02, 2019 |
|
How the CMO of Sage Therapeutics Positioned a New Indication for FDA Approval
|
Dec 02, 2019 |
|
Addressing the Talent Gap in Biotech - Recruit and Retain
|
Dec 02, 2019 |
|
How to Navigate the Development Path from CMO to CEO
|
Dec 01, 2019 |
|
How do Patients Become Partners in the Sharing of Data to Advance Science?
|
Nov 06, 2019 |
|
Best Practices for Pharma - Patient Advocacy Partnerships
|
Nov 05, 2019 |
|
Merck's Next Phase of Patient Centricity in R&D
|
Nov 04, 2019 |
|
Clinical update on AMG 420, an anti-BCMA BiTE®
|
Nov 01, 2019 |
|
Connecting Employee-Centric Culture to Patient-Centric Culture
|
Nov 01, 2019 |
|
Eliciting Patient Experience Data to Understand Medicines Benefits/Disadvantages
|
Oct 31, 2019 |
|
Understanding the Language of Patients - The Value of Health Literacy
|
Oct 30, 2019 |
|
UCB and Parkinson's UK Collaboration Improve a Trial through Patient Involvement
|
Oct 29, 2019 |
|
Improving T Cell Therapies via Next Generation Technologies
|
Oct 17, 2019 |
|
Monetizing Science: Turning an Asset into Value through IPOs
|
Oct 16, 2019 |
|
IDO Changes the T-cell Balance in the Tumor Microenvironment
|
Oct 16, 2019 |
|
Insights from Deal Trends: Betting on Tumor Immunology
|
Aug 29, 2019 |
|
Living with Alzheimer’s from a Young Patient's Perspective
|
Aug 23, 2019 |
|
Organizational and Digital Restructuring to Scale Mobile Clinical Trials
|
Aug 23, 2019 |
|
How to Align the Promise of Technology with the Patient Voice
|
Aug 22, 2019 |
|
The Role of Digital Biomarkers and the Impact on Drug Delivery
|
Aug 22, 2019 |
|
PODD: Partnership Opportunities in Drug Delivery 2019 Overview in 4 Minutes
|
Aug 20, 2019 |
|
A Patient Perspective on Living with Parkinson's Disease and the GDNF Trial
|
Aug 19, 2019 |
|
The Future of Mobile Data in Clinical Trials: Challenges and Opportunities
|
Aug 15, 2019 |
|
Eli Lilly: How to Launch Multiple Mobile Devices in a Hybrid Setting
|
Aug 15, 2019 |
|
Pfizer’s Atopic Dermatitis Clinical Trial with Digital Wearable Technology
|
Aug 08, 2019 |
|
Merck’s Digital Health and Al Strategy: Progress Report
|
Aug 07, 2019 |
|
How Digital Biomarker Innovation is Modernizing Clinical Endpoints
|
Jul 31, 2019 |
|
Regenerative Medicine as a Disrupter in Clinical Trials
|
Jul 30, 2019 |
|
6th Annual Mobile in Clinical Trials: What to Expect in 4 Minutes
|
Jul 29, 2019 |
|
Estonia, The Digital Republic: Where Patients Own Their Data
|
Jul 29, 2019 |
|
Co-Creating the Industry's Scalable Solution for EHR
|
Jul 28, 2019 |
|
Bringing Blockchain to Life: Digitizing Clinical Supply Chain in Trials
|
Jul 27, 2019 |
|
Bayer: Virtual Assistants for Sites and Patients in Clinical Trials
|
Jul 26, 2019 |
|
DPharm: Disruptive Innovations in Clinical Trials 2019 Overview in 5 Minutes
|
Jul 25, 2019 |
|
Entrepreneur Data Scientist, Ben Liu on Solving Bottlenecks in Clinical Research
|
Jul 23, 2019 |
|
Stories from Bioinspiration to Innovation
|
Jul 22, 2019 |
|
Including Wellness in the Pharma Model - How Drug Delivery will be a Key Enabler
|
Jul 21, 2019 |
|
Service & Patients in Clinical Trials
|
Jul 21, 2019 |
|
Panel: Delivering mRNA Drugs and Vaccines – Progress and Future Outlook
|
Jul 20, 2019 |
|
How to Innovate like Amazon to Modernize Clinical Trials
|
Jul 11, 2019 |
|
Alzheimer’s Studies: Exploring Registries to Improve Enrollment & Trial Design
|
Jun 25, 2019 |
|
4th Annual IO Combinations 360°: What to Expect in 8 Minutes
|
May 23, 2019 |
|
CAR-T Therapy: Optimization Through Engineering T-cells or Combinations
|
May 02, 2019 |
|
Combining IO Modalities In a Cost Effective, Patient Beneficial Manner
|
May 01, 2019 |
|
IO Partnering Strategies In an Increasingly Complex Environment
|
Apr 30, 2019 |
|
Next Generation Biomarker and Companion Diagnostics for Predicting Response
|
Apr 29, 2019 |
|
Innovations in Immuno-Oncology Imaging
|
Apr 25, 2019 |
|
2nd Annual Drug Delivery West - 5 Minute Overview
|
Apr 05, 2019 |
|
Modernizing Clinical Trials with IQVIA's Dr Cynthia Verst
|
Apr 01, 2019 |
|
Integrating Care and Research with Dr Laura Esserman
|
Mar 27, 2019 |
|
Drug Delivery Global Health Challenge
|
Mar 04, 2019 |
|
Patient Perspectives on Drug Delivery Needs Present and Future
|
Feb 25, 2019 |
|
What are the Regulatory and Ethical Concerns of Integrating Care and Research?
|
Feb 06, 2019 |
|
How Can We Work with Medical Practices to Offer Patients Clinical Trials?
|
Feb 05, 2019 |
|
Why Are Clinical Trials Not Typically a Care Option?
|
Feb 05, 2019 |
|
How to Move Clinical Research into Communities That Would Truly Benefit
|
Feb 04, 2019 |
|
Lessons Learned from a Veteran Biotech and Investor MD
|
Feb 04, 2019 |
|
Case Study: Preparing for the Challenges of Late Stage Trials
|
Feb 01, 2019 |
|
Should Patients Have the Right to Try?
|
Jan 31, 2019 |
|
Best Practices in Communication and PR Strategy
|
Jan 30, 2019 |
|
Translating Patient Insight and Patient Experience Internally into Deliverables
|
Jan 24, 2019 |
|
Progress and Future Outlook of Cancer Immunotherapy
|
Jan 23, 2019 |
|
Panel: Engaging Patients By Giving Them their Data
|
Jan 22, 2019 |
|
Mobile Technology in Clinical Trials: Clinical Trials Transformation Initiative
|
Jan 15, 2019 |
|
How GSK Implemented Pivotal End-to-End Engagement Initiatives at Different Stage
|
Jan 14, 2019 |
|
How to Make Patient Involvement Sustainable Throughout Medicines Development
|
Jan 12, 2019 |
|
What Does a Truly Patient-Centered Healthcare System Look Like in 5-10 Years?
|
Jan 11, 2019 |
|
6th Annual Patients as Partners US: What to Expect in 8 Minutes
|
Jan 09, 2019 |
|
How Partnering with Medical Research Charities is Key to Medicines Development
|
Jan 09, 2019 |
|
Patients as Partners Europe 3rd Annual What to Expect in 5 Minutes
|
Dec 24, 2018 |
|
How Tesaro is Integrating the Patient in the Clinical Development Process
|
Dec 12, 2018 |
|
Keytruda in Combo with Chemo in NSCLC
|
Dec 11, 2018 |
|
Future Value Generation in Immuno-Oncology
|
Dec 05, 2018 |
|
Reflections of the Cancer Moonshot and Future of the Biden Cancer Initiative
|
Dec 04, 2018 |
|
Balancing Benefit and Toxicity from Immunotherapeutics
|
Dec 04, 2018 |
|
The BioCentury Report on Immuno-Oncology Industry Trends
|
Nov 28, 2018 |
|
5th Annual Immuno-Oncology 360˚: 12 minutes of What to Expect
|
Nov 19, 2018 |
|
Partnership Opportunities in Drug Delivery 2018: What to Expect 5 Min Podcast
|
Sep 08, 2018 |
|
Podcast: From a Zimbabwean Village Kid to a PhD Regenerative Medicine Student
|
Aug 30, 2018 |
|
All of Us Research Program, a Nation-wide Initiative from the NIH
|
Aug 17, 2018 |
|
Reimagining Clinical Trials with Entrepreneur, Dr Ben Liu, CEO, Trialspark
|
Aug 17, 2018 |
|
Blockchain Opportunities for Patient Data Donation and Clinical Research
|
Aug 16, 2018 |
|
DPharm Podcast: What to Expect at the 2018 Event in 8 Minutes
|
Aug 16, 2018 |
|
Mobile in Clinical Trials Podcast: 3 1/2 Minutes on What to Expect
|
Aug 15, 2018 |
|
What to Expect at Rational Combinations 360° 2018 - 5 Min Overview
|
Jul 19, 2018 |
|
How to Innovate in the Drug Delivery Space
|
Jun 23, 2018 |
|
Key Trends in Drug Delivery: Expert Perspective
|
Jun 23, 2018 |
|
How FARA and Horizon Pharma Partnered to Improve Clinical Development
|
Jun 22, 2018 |
|
How Takeda Used One or More of the Various Patient Engagement Frameworks
|
Jun 22, 2018 |
|
How Patient Research Advocates are Driving R&D: A Patient Case Study
|
Jun 21, 2018 |
|
Fireside Chat: Lessons Learned from a Drug Delivery Pioneer and Risk-Taker
|
Jun 21, 2018 |
|
Nanotechnology Keynote
|
Jun 07, 2018 |
|
Utilizing a Device Platform Technology across Multiple Therapeutic Categories
|
Jun 07, 2018 |
|
CEO Keynote Fireside Chat
|
Jun 06, 2018 |
|
Addressing R&D Challenges using Drug Delivery Technologies
|
Jun 05, 2018 |
|
Panel: Hitting the "Reset" Button on Direct-to-CNS Delivery
|
Jun 04, 2018 |
|
Current and Emerging Drug Delivery Needs in Oncology
|
Jun 04, 2018 |
|
Building Blocks of IO Clinical Trials - Part 2
|
May 11, 2018 |
|
Building Blocks of IO Clinical Trials - Part 1
|
May 10, 2018 |
|
Endpoints News Industry Report on IO Collaborations and Trends
|
May 09, 2018 |
|
CTTI Report - Mobile Clinical Trials Program: Recommendations on Novel Endpoints
|
Apr 30, 2018 |
|
How a Mobile App Can Offer Unique Value in Assessing Patient Reported Outcomes
|
Apr 29, 2018 |
|
Lessons Learned from the Journey of a CMO Leader, Michael Rosenblatt, MD
|
Apr 18, 2018 |
|
Developing a Pathway for Compassionate Use Cases
|
Apr 17, 2018 |
|
2018 Chief Medical Officer Summit Podcast Overview in a Nutshell
|
Apr 17, 2018 |
|
Clinical Research as a Care Option, 2nd annual - 3 min Podcast Overview
|
Mar 04, 2018 |
|
What to Expect at Clinical Trial Collaborations 2018 – 5 min Podcast
|
Mar 04, 2018 |
|
Mobile in Clinical Trials Europe New for 2018 - 4 min Podcast Overview
|
Mar 01, 2018 |
|
Patients, a Seat at the Table in Clinical Trials with Pfizer’s Dr Roz Schneider
|
Mar 01, 2018 |
|
Reducing the Burden of Type 1 Diabetes with Patient Dana Lewis:DPharm Podcast #5
|
Feb 19, 2018 |
|
5th Annual Patients as Partners What to Expect Overview Podcast in 7 Minutes
|
Feb 19, 2018 |
|
Wireless Remote Monitoring – DPharm Podcast Series #2
|
Feb 17, 2018 |
|
Immuno-Oncology Clinical Trial Operations 4 Min Summary of What to Expect
|
Jan 28, 2018 |
|
Patients as Partners EU Overview in 3 Minutes
|
Dec 27, 2017 |
|
Roche's Dr Barbara Lueckel Reviews the 2016 Drug Delivery Industry
|
Sep 26, 2017 |
|
From the Olympics to Clinical Research
|
Sep 22, 2017 |
|
What to Expect at Immuno-Oncology 360° 2018
|
Sep 20, 2017 |
|
Why Pharma R&D has to Start Thinking Like a Service Industry and How?
|
Aug 24, 2017 |
|
The Gap Between Clinical Care, Patient Involvement & What Patients Want
|
Jun 27, 2017 |
|
Digital Solutions Impacting the Economic Efficacy of Clinical Trials
|
Jun 26, 2017 |
|
Partnering with Patient Organizations for Advancing Cures
|
Jun 23, 2017 |
|
Challenges and Opportunities in Pursuing a New Therapeutic Modality
|
Jun 23, 2017 |
|
Partnering with Patients in the Development and Lifecycle of Medicines
|
Jun 22, 2017 |
|
Trends and Collaborations in the IO Space
|
Jun 22, 2017 |
|
Unlocking the Power of Patient Engagement within Clinical and Commercial
|
Jun 21, 2017 |
|
Patients Influencing Policy in the EU
|
Jun 21, 2017 |
|
Immuno-Oncology 360°: Business Models for Complex Science by Dr Axel Hoos of GSK
|
Jun 21, 2017 |
|
Increasingly Critical Role of Predictive Biomarkers in Cancer Immunotherapy
|
Jun 20, 2017 |
|
Addressing Clinical Challenges in Immuno-Oncology
|
Jun 20, 2017 |
|
Innovative Ways of Patient Involvement in Medicines Development
|
Jun 20, 2017 |
|
Important Business Aspects of Immuno-Oncology: Issues and Controversies
|
Jun 20, 2017 |
|
Sequencing of Combination Agents in Immuno-Oncology with Dr Charles Drake
|
Jun 16, 2017 |
|
Next Generation of Combination Immunotherapy with Dr Patrick Hwu of MD Anderson
|
Jun 07, 2017 |
|
5 Minute Overview of DPharm (Disrupting Clinical Trials) Europe: What to Expect?
|
Jan 26, 2017 |
|
Patients as Partners Europe 7 Minute Overview on What to Expect?
|
Jan 26, 2017 |
|
Immuno-Oncology 360 Conference in 5 Minutes: What to Expect?
|
Jan 26, 2017 |
|
DPharm Team Discuss 2016 Highlights
|
Aug 12, 2016 |
|
Pfizer's Blue Sky Approach to Help Transform Clinical Research
|
Aug 10, 2016 |
|
Communicating the Good, Bad & Ugly for CMOs and R&D Leaders in Biotech
|
May 16, 2016 |
|
Clinical Trial Opportunities in Puerto Rico
|
May 13, 2016 |
|
Alternative Model to Transform a Funding Gap in Rare Disease Clinical Research
|
Apr 07, 2016 |
|
A New Economic Solution to Drive Cures to Patients
|
Apr 01, 2016 |
|
Partnering with Patients in the Development & Lifecycle of Medicines
|
Jan 21, 2016 |
|
Immuno-Oncology Drug Development: Challenges & Next Steps
|
Dec 21, 2015 |
|
Making Clinical Trials a Care Option for Patients: Piloting an Infrastructure
|
Dec 07, 2015 |
|
Safety Elements of Cancer Immunotherapies: Immune Related Adverse Events
|
Nov 10, 2015 |
|
How the Availability of Capital Impacts the Role of the CMO
|
Oct 19, 2015 |
|
How Investors Assess R&D Biotech Management
|
Oct 19, 2015 |
|
The Journey of a Physician CEO with David Schenkein, MD, CEO, Agios
|
Sep 21, 2015 |
|
Clinical Air Episode #14 Consumer Electronics in Clinical Research
|
Jul 21, 2015 |
|
Immuno-Oncology: Exploring the Challenges & Potential
|
Jun 04, 2015 |
|
Design Thinking for Clinical Trials
|
Apr 20, 2015 |
|
Clinical Air Episode #13 Transcelerate & Industry Engagement
|
Jan 16, 2015 |
|
Risk Based Monitoring: New Thinking on Clinical Oversight
|
Oct 21, 2014 |
|
Clinical Air Episode # 12: Digital Startups & Applications for Clinical Research
|
Aug 29, 2014 |
|
Clinical Air Episode #11: How can Digital Complement and Disrupt Clinical Trials
|
Aug 15, 2014 |
|
Clinical Air Episode # 10 Patients as Partners in Clinical Trials
|
May 29, 2014 |
|
Clinical Air Episode # 9 Investing in the Future of Clinical Research
|
May 29, 2014 |
|
Clinical Air Episode # 8: Investigators as Partners in Clinical Research
|
May 27, 2014 |
|
Clinical Air Episode # 7: Engaging Patients by Sharing Electronic Clinical Data
|
Feb 20, 2014 |
|
Clinical Air #6 Clinical Trial Visits of the Future
|
Jan 09, 2014 |
|
Barriers and Limitations in Engaging Patients in Clinical Trials
|
Jan 06, 2014 |
|
Clinical Air Episode #5 Applications for Mobile/Sensors in Clinical Research
|
Dec 10, 2013 |
|
Clinical Air Episode #4 Clinical Innovation Continuum
|
Oct 28, 2013 |
|
Clinical Air Episode #3 Dpharm & Beyond
|
Oct 08, 2013 |
|
Clinical Air Episode #2:To Serve Patients in Clinical Trials
|
Sep 10, 2013 |
|
Managing the Role of Chief Medical Officer in a Biotech
|
Sep 06, 2013 |
|
Navigating the Complexities of Global Clinical Trials
|
Aug 28, 2013 |
|
Clinical Air Episode #1: Clinical Trial Calling
|
Aug 12, 2013 |